Simcere Pharmaceutical Group Limited
SMHGF
$0.6486
-$0.0621-8.74%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 101.87M | -25.31M | -152.25M | -21.53M | 112.83M |
| Total Depreciation and Amortization | 41.82M | 41.32M | 40.74M | 40.89M | 41.20M |
| Total Amortization of Deferred Charges | 5.13M | 4.37M | 3.60M | 3.07M | 2.53M |
| Total Other Non-Cash Items | 56.39M | 222.04M | 387.08M | 191.35M | -8.85M |
| Change in Net Operating Assets | -11.92M | -69.74M | -127.33M | -127.33M | -127.33M |
| Cash from Operations | 193.28M | 172.69M | 151.86M | 86.45M | 20.38M |
| Capital Expenditure | -49.74M | -58.39M | -66.82M | -66.82M | -66.82M |
| Sale of Property, Plant, and Equipment | 6.98M | 11.69M | 16.36M | 16.36M | 16.36M |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | 4.75M | 5.85M | 6.91M | 74.24M | 143.19M |
| Other Investing Activities | -108.05M | -78.46M | -48.76M | 8.15M | 66.01M |
| Cash from Investing | -146.07M | -119.32M | -92.30M | 31.94M | 158.74M |
| Total Debt Issued | 1.25B | 1.42B | 1.59B | 1.40B | 1.22B |
| Total Debt Repaid | -1.50B | -1.54B | -1.58B | -1.47B | -1.37B |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -687.99M | -664.88M | -641.78M | -465.43M | -289.07M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -55.95M | -57.07M | -57.97M | -57.97M | -57.97M |
| Other Financing Activities | 934.19M | 930.03M | 925.87M | 445.20M | -35.47M |
| Cash from Financing | -56.96M | -37.15M | -17.02M | -71.37M | -126.72M |
| Foreign Exchange rate Adjustments | 318.10K | 327.90K | 336.70K | 509.00K | 686.20K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -9.43M | 16.54M | 42.88M | 47.53M | 53.09M |